Patient-controlled Intravenous Analgesia Enhanced Recovery After Surgery

Announcing a new article publication for BIO Integration journal. In this article the authors Haojie Yang, Yingzhe Yan, Qian Xie and colleagues from Sun Yat-sen University, Guangzhou, China and The First Affiliated Hospital of Jinan University, Guangzhou, China, discuss patient-controlled intravenous analgesia enhanced recovery after surgery.

Patient-controlled intravenous analgesia (PCIA) is an increasingly used method to control postoperative pain. The authors of this article aimed to investigate the association between PCIA and recovery after flap reconstruction in patients with oral squamous cell carcinoma (OSCC).

Patients with OSCC who underwent flap reconstruction between 2016 and 2020 were reviewed (n=850). Baseline characteristics were compared between PCIA and non-PCIA groups. Propensity score matching (PSM) (1:4) was introduced to eliminate these confounding factors (n=505). Univariate analysis was performed to compare matched PCIA and non-PCIA group. Univariate and multivariate analyses were performed before and after PSM to identify factors that influenced length of stay (LOS) in hospital. The differences in characteristics of matched and unmatched groups were also compared.

Before PSM, the differences in flap types, smoking status, and radiotherapy history between PCIA and non-PCIA groups were statistically significant (P<0.05). After these factors were matched by PSM, LOS was 1.5 days shorter in the matched PCIA group than in the non-PCIA group (median, 10.5 versus 12.0, P=0.006). There was no significant difference in flap or medical complications, reoperations, or postoperative neutrophil-to-lymphocyte ratio (NLR) between the matched PCIA and non-PCIA groups. Postoperative glucose was lower in the matched PCIA group than in the non-PCIA group (median, 6.70 versus 7.30 mmol/L, P=0.021). Prolonged LOS was associated with postoperative PCIA, flap types, preoperative NLR, intraoperative red blood cell transfusion, fluid infusion rate over 24 h, and postoperative intensive care unit admission (P<0.05).

Patients with OSCC using PCIA after flap reconstruction surgeries have a reduced LOS in hospital compared with those who used conventional postoperative analgesic strategies. Moreover, postoperative glucose increase was lower in the PCIA group than in the non-PCIA group.

Article reference: Haojie Yang, Yingzhe Yan, Qian Xie et al Patient-controlled Intravenous Analgesia Enhanced Recovery After Surgery by Reducing Length of Hospital Stay in Patients with Oral Squamous Cell Carcinoma Who Underwent Flap Reconstruction: A Propensity Score-matched Study. BIO Integration, 2021,

BIO Integration is fully open access journal which will allow for the rapid dissemination of multidisciplinary views driving the progress of modern medicine.

As part of its mandate to help bring interesting work and knowledge from around the world to a wider audience, BIOI will actively support authors through open access publishing and through waiving author fees in its first years. Also, publication support for authors whose first language is not English will be offered in areas such as manuscript development, English language editing and artwork assistance.

BIOI is now open for submissions; articles can be submitted online at:

Please visit to learn more about the journal.

Editorial Board:

Please visit to learn more about the journal.

Editorial Board:

BIOI is available on the IngentaConnect platform ( and at the BIO Integration website (

Submissions may be made using ScholarOne (

There are no author submission or article processing fees.

Follow BIOI on Twitter @JournalBio; Facebook ( and LinkedIn (

ISSN 2712-0074

eISSN 2712-0082

Keywords: Patient-controlled intravenous analgesia (PCIA), length of stay (LOS), enhanced recovery after surgery

(ERAS), oral squamous cell carcinoma (OSCC)